HCWB
HCW Biologics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.87
+0.00%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$1.08
- Revenue estimate
- $119.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$12
- EPS estimate
- -$1.98
- Revenue actual
- $135.6K
- Revenue estimate
- $135.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -185.4%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026